PREdiabetes GLycemic Impact and Data Evaluation
Recruiting now · Not applicable
Conditions studied: Pre Diabetic, Obesity & Overweight, Insulin Resistance
In brief
This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.
Key facts
- Study ID
- NCT07599072
- Run by
- Nazarii Kobyliak
- People needed
- 80
- Starts
- 2026-07-01
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-06-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age of 18 years and older.
- Presence of prediabetes diagnosed according to criteria of the American Diabetes Association
- Persons who treated with diet and exercise alone or metformin on a stabilized dose for at least 3 months before the study;
- Ability to comply with protocol requirements and maintain a patient diary.
- Signed informed consent.
You may not qualify if…
- Presence of type 1 or type 2 diabetes;
- Decompensated liver or kidney diseases (GFR < 45 ml/min/1. 73 m²);
- Active cardiovascular diseases within 12 months of Visit 1, such as myocardial infarction, clinically significant arrhythmia, unstable angina, coronary artery bypass surgery, or angioplasty; or are expected to require coronary artery bypass surgery or angioplasty during the course of the study;
- Endocrine disorders (e.g., Itsenko-Cushing syndrome, acromegaly) that affect glycemia;
- Pregnancy or lactation;
- Mental or cognitive impairments that would interfere with study participation;
- Daily use of any form of steroid medication (oral, inhaled, injected) within the last 3 months;
- Recent use of any CGM within the last 12 months;
- Known allergy to sensor materials;
- Has evidence of current abuse of drugs or alcohol or a history of abuse that, in the investigator's opinion, would cause the individual to be noncompliant;
- Participation in another clinical study within the last 3 months.
Where it is running
- Bogomolets National Medical University — Kyiv, Ukraine (enrolling)
- University Hospital of Bogomolets National Medical University — Kyiv, Ukraine (enrolling)
- Bogomoletz Institute of Physiology — Kyiv, Ukraine
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.